NextCure, Inc.
NXTC
$0.4446
-$0.0039-0.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.87% | -4.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.69% | -0.32% | |||
| Operating Income | 6.69% | 0.32% | |||
| Income Before Tax | 5.40% | -0.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.40% | -0.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.40% | -0.55% | |||
| EBIT | 6.69% | 0.32% | |||
| EBITDA | 6.90% | 0.12% | |||
| EPS Basic | 5.41% | -0.44% | |||
| Normalized Basic EPS | 5.41% | -0.43% | |||
| EPS Diluted | 5.41% | -0.44% | |||
| Normalized Diluted EPS | 5.41% | -0.43% | |||
| Average Basic Shares Outstanding | 0.00% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||